Unum Therapeutics

Unum Therapeutics

Developing our universal Antibody-Coupled T cell Receptor (ACTR, pronounced ‘actor’) therapy to address the limitations of other T cell approaches
Cambridge United States (HQ)

Unum Therapeutics Company information

Edit
Date
Employees
46 people
Firm valuation
€236—355m (Dealroom.co estimates Jun 2015.)
  • Edit

Recent News about Unum Therapeutics

Edit
LocationEdit
Cambridge, MA, USA
Are you an employee or an investor of this company?
Add your profile